Basics Rocket Pharmaceuticals, Inc. Rocket Pharmaceuticals Inc, formerly Inotek Pharmaceuticals Corp, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. IPO Date: February 18, 2015 Sector: Healthcare Industry: Biotech Market Cap: $302.74M Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 3.06% Avg Daily Range (30 D): $0.12 | 4.05% Avg Daily Range (90 D): $0.24 | 4.73% Institutional Daily Volume Avg Daily Volume: .66M Avg Daily Volume (30 D): 3.23M Avg Daily Volume (90 D): 3.91M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 184 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 2,662 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $1.6M Avg Inst. Trade (90 D): $1.58M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $1.56M Avg Closing Trade (90 D): $1.87M Avg Closing Volume: 129.31K     News Jul 22, 2025 @ 7:49 PM ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket Ph... Source: Rosen Law Firm Jul 22, 2025 @ 7:44 PM VRA Investor News: If You Have Suffered Losses in ... Source: Rosen Law Firm Jul 21, 2025 @ 3:00 PM INVESTOR ALERT: Class Action Lawsuit Filed on Beha... Source: Holzer & Holzer, Llc Jul 20, 2025 @ 2:38 PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LL... Source: Faruqi & Faruqi, Llp Jul 19, 2025 @ 2:19 PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ... Source: Rosen Law Firm Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.56 $-.71 $-.74 Diluted EPS $-.56 $-.71 $-.74 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -61.33M $ -66.72M $ -69.65M Operating Income / Loss $ -64.39M $ -69.42M $ -73.71M Cost of Revenue $ $ $ Net Cash Flow $ M $ 26.99M $ 3.33M PE Ratio     Splits Jan 05, 2018:   1:4